| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |